Suppr超能文献

生酮饮食治疗耐药性癫痫痉挛的疗效。

Ketogenic diet efficacy in the treatment of intractable epileptic spasms.

机构信息

Division of Neurology, Department of Pediatrics, Children's Mercy Hospitals and Clinics, University of Missouri in Kansas City, Missouri.

Division of Neurology, Department of Pediatrics, Children's Mercy Hospitals and Clinics, University of Missouri in Kansas City, Missouri.

出版信息

Pediatr Neurol. 2014 Mar;50(3):224-7. doi: 10.1016/j.pediatrneurol.2013.11.021. Epub 2013 Dec 4.

Abstract

OBJECTIVE

To determine the efficacy of the ketogenic diet in controlling epileptic spasms after failing traditional antiepileptic medication therapy.

METHODS

This is a prospective, case-based study of all infants with epileptic spasms who were referred for treatment with the ketogenic diet at our hospital between 2009 and 2012. All subjects continued to have epileptic spasms with evidence of hypsarrhythmia or severe epileptic encephalopathy on electroencephalography despite appropriate medication treatments. The diet efficacy was assessed through clinic visits, phone communications, and electroencephalography. Quality of life improvement was charted based on the caregiver's perspective.

RESULTS

Twenty infants (15 males) were included in the study. The mean age at seizure onset was 4.5 months. Age at ketogenic diet initiation was 0.3 to 2.9 years (mean 1.20, standard deviation 0.78). Fifteen patients had epileptic spasms of unknown etiology; three had perinatal hypoxic ischemic encephalopathy, one had lissencephaly, and one had STXBP1 mutation. Fifteen infants failed to respond to adrenocorticotropin hormone and/or vigabatrin before going on the ketogenic diet. Three months after starting the diet, >50% seizure reduction was achieved in 70% of patients (95% CI 48-86). These results were maintained at 6- and 12-month intervals. All eight of the patients followed for 24 months had >50% seizure reduction (95% CI 63-100). At least 90% seizure reduction was reported in 20% of patients at 3 months (95% CI 7-42), 22% (95% CI 8-46) at 6 months, and 35% (95% CI 17-59) at 12 months. The majority of patients (63%) achieved improvement of their spasms within 1 month after starting the diet. Sixty percent of patients had electroencephalographic improvement. All caregivers reported improvement of the quality of life at the 3-month visit (95% confidence interval 81-100). This ratio was 94% at 6 months (95% CI 72-99) and 82% at 12 months (95% CI 58-95).

CONCLUSION

The ketogenic diet is a safe and potentially effective method of treatment for patients with epileptic spasms, especially those who do not respond to customary medication therapies.

摘要

目的

确定生酮饮食在传统抗癫痫药物治疗失败后控制癫痫性痉挛的疗效。

方法

这是一项针对 2009 年至 2012 年期间在我院接受生酮饮食治疗的所有癫痫性痉挛婴儿的前瞻性、基于病例的研究。所有患者在接受适当的药物治疗后,脑电图仍显示有高度节律失常或严重癫痫性脑病,仍存在癫痫性痉挛。通过临床访视、电话沟通和脑电图评估饮食的疗效。根据照顾者的观点来记录生活质量的改善情况。

结果

研究纳入 20 名婴儿(男 15 例)。发病年龄平均为 4.5 个月。生酮饮食开始年龄为 0.3 至 2.9 岁(平均 1.20,标准差 0.78)。15 例患者癫痫性痉挛病因不明;3 例有围产期缺氧缺血性脑病,1 例有无脑回畸形,1 例有 STXBP1 突变。15 名婴儿在使用促肾上腺皮质激素和/或氨己烯酸之前未能对治疗产生反应。开始饮食治疗 3 个月后,70%(95%可信区间 48-86)的患者癫痫发作减少了>50%。这些结果在 6 个月和 12 个月的间隔时间内保持不变。随访 24 个月的 8 名患者中有 8 名(95%可信区间 63-100)癫痫发作减少了>50%。3 个月时,20%(95%可信区间 7-42)的患者报告至少减少 90%的癫痫发作,6 个月时 22%(95%可信区间 8-46),12 个月时 35%(95%可信区间 17-59)。大多数患者(63%)在开始饮食后 1 个月内痉挛得到改善。60%的患者脑电图有改善。所有照顾者在 3 个月访视时报告生活质量改善(95%置信区间 81-100)。6 个月时这一比例为 94%(95%可信区间 72-99),12 个月时为 82%(95%可信区间 58-95)。

结论

生酮饮食是治疗癫痫性痉挛患者的一种安全且可能有效的方法,特别是那些对常规药物治疗无反应的患者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验